-
サマリー
あらすじ・解説
Plus: An obesity-drug candidate from Amgen helped patients lose 20% of their body weight in a midstage study, at the low end of expectations. Walmart plans to end some of its diversity programs under pressure from a conservative activist. J.R. Whalen reports. Sign up for the WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices